The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis

Smad7 was initially identified as an inhibitor of Transforming growth factor (TGF)-β due mainly to its ability to bind TGF-β receptor type I and prevent TGF-β-associated Smad signaling. More recently, it has been demonstrated that Smad7 can interact with other intracellular proteins and regulate also TGF-β-independent signaling pathways thus making a valid contribution to the neoplastic processes in various organs. In particular, data emerging from experimental studies indicate that Smad7 may differently modulate the course of various tumors depending on the context analyzed. These observations, together with the demonstration that Smad7 expression is deregulated in many cancers, suggest that therapeutic interventions around Smad7 can help interfere with the development/progression of human cancers. In this article we review and discuss the available data supporting the role of Smad7 in the modulation of cancer growth and progression.

• Publication year

  2013

• Venue

  International Journal of Molecular Sciences

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/ijms141223774PMID 24317436PMCID 3876077
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro

  2013cited by this paper
• MicroRNA‐216a/217‐induced epithelial‐mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer

  2013influential reference
• MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7.

  2013cited by this paper
• TGF-&bgr; signaling and epithelial–mesenchymal transition in cancer progression

  2013cited by this paper
• Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells.

  2012cited by this paper
• Differential effect of the expression of TGF‐β pathway inhibitors, Smad‐7 and Ski, on invasive breast carcinomas: relation to biologic behavior

  2012cited by this paper
• The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer

  2012cited by this paper
• APC and Smad7 link TGFβ type I receptors to the microtubule system to promote cell migration

  2012cited by this paper
• Smad4 inactivation promotes malignancy and drug resistance of colon cancer.

  2011cited by this paper
• Inhibitory Smad7: emerging roles in health and disease.

  2011cited by this paper
• Smad7 expression in T cells prevents colitis-associated cancer.

  2011cited by this paper
• Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.

  2011cited by this paper
• Smad7 and Smad6 bind to discrete regions of Pellino-1 via their MH2 domains to mediate TGF-beta1-induced negative regulation of IL-1R/TLR signaling.

  2010cited by this paper
• Smad7 restricts melanoma invasion by restoring N‐cadherin expression and establishing heterotypic cell–cell interactions in vivo

  2010influential reference
• Increased risk of colon cancer associated with a genetic polymorphism of SMAD7.

  2010cited by this paper
• Smad signaling is required to maintain epigenetic silencing during breast cancer progression.

  2010cited by this paper
• Antimetastatic role of Smad4 signaling in colorectal cancer.

  2010cited by this paper
• Low-Level Expression of Smad7 Correlates with Lymph Node Metastasis and Poor Prognosis in Patients with Pancreatic Cancer

  2009cited by this paper
• Smad7 Is Required for the Development and Function of the Heart*

  2009cited by this paper
• Association of common genetic variants in SMAD7 and risk of colon cancer.

  2009cited by this paper
• Nuclear Function of Smad7 Promotes Myogenesis

  2009cited by this paper
• Ski and SnoN, potent negative regulators of TGF-β signaling

  2009cited by this paper
• Smad4/Smad7 balance: a role of tumorigenesis in gastric cancer.

  2009influential reference
• Smad7 induces hepatic metastasis in colorectal cancer

  2008cited by this paper
• Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21

  2008cited by this paper
• A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk

  2007cited by this paper
• Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway.

  2007cited by this paper
• Smad7 Antagonizes Transforming Growth Factor β Signaling in the Nucleus by Interfering with Functional Smad-DNA Complex Formation

  2007cited by this paper
• Inhibition of Smad7, a negative regulator of TGF-beta signaling, suppresses autoimmune encephalomyelitis.

  2007cited by this paper
• A 4.3 kb Smad7 promoter is able to specify gene expression during mouse development.

  2007cited by this paper
• Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis.

  2007cited by this paper
• Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2

  2007cited by this paper
• Deletion of Exon I of SMAD7 in Mice Results in Altered B Cell Responses

  2006cited by this paper
• Smad7-induced beta-catenin degradation alters epidermal appendage development.

  2006cited by this paper
• Smad7: Licensed to Kill β-Catenin

  2006cited by this paper
• Smad7-Induced β-Catenin Degradation Alters Epidermal Appendage Development

  2006cited by this paper
• Smad7 Promotes and Enhances Skeletal Muscle Differentiation

  2006cited by this paper
• In vivo disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions in the pancreas.

  2006cited by this paper
• Smad7: licensed to kill beta-catenin.

  2006cited by this paper
• Smad transcription factors.

  2005cited by this paper
• 2-Methoxyestradiol-induced Apoptosis in Prostate Cancer Cells Requires Smad7*

  2005cited by this paper
• Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer.

  2005cited by this paper
• Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo

  2005cited by this paper
• Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.

  2005cited by this paper
• Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.

  2005cited by this paper
• NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor

  2005cited by this paper
• NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.

  2005cited by this paper
• Overexpression of the TGF-β antagonist Smad7 in endometrial cancer

  2005cited by this paper
• Smad7 Abrogates Transforming Growth Factor-β1-mediated Growth Inhibition in COLO-357 Cells through Functional Inactivation of the Retinoblastoma Protein*

  2005cited by this paper
• Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease.

  2005cited by this paper
• Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.

  2004cited by this paper
• Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas.

  2004cited by this paper
• Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.

  2004cited by this paper
• GADD34–PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor

  2004cited by this paper
• Thioredoxin Is Downstream of Smad7 in a Pathway That Promotes Growth and Suppresses Cisplatin-Induced Apoptosis in Pancreatic Cancer

  2004cited by this paper
• Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection.

  2004cited by this paper
• Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.

  2003influential reference
• SMAD7 is a prognostic marker in patients with colorectal cancer

  2003cited by this paper
• Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.

  2003cited by this paper
• Metastasis is driven by sequential elevation of H-ras and Smad2 levels

  2002cited by this paper
• Smads mediate signaling of the TGFβ superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis

  2001cited by this paper
• Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.

  2001cited by this paper
• Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation*

  2001cited by this paper
• Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7

  2001cited by this paper
• Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells.

  2000cited by this paper
• A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.

  2000cited by this paper
• Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells

  2000cited by this paper
• Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.

  2000cited by this paper
• The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.

  2000cited by this paper
• A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA

  2000cited by this paper
• Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein

  1999cited by this paper
• Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

  1999cited by this paper
• Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway

  1999cited by this paper
• A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.

  1999influential reference
• Specificity, diversity, and regulation in TGF-beta superfamily signaling.

  1999cited by this paper
• Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.

  1999cited by this paper
• The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling.

  1999cited by this paper
• Specificity, diversity, and regulation in TGF‐β superfamily signaling

  1999cited by this paper
• The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer

  1999influential reference
• Increased smad expression and activation are associated with apoptosis in normal and malignant prostate after castration.

  1999cited by this paper
• The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.

  1999cited by this paper
• Smad3 mutant mice develop metastatic colorectal cancer.

  1998cited by this paper
• Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.

  1998cited by this paper
• Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members.

  1998cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling.

  1997cited by this paper
• The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling

  1997cited by this paper
• Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling.

  1997cited by this paper
• Frequency of Smad gene mutations in human cancers.

  1997cited by this paper
• Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling

  1997cited by this paper
• Homozygous deletion map at 18q21.1 in pancreatic cancer.

  1996cited by this paper
• Tumor invasion and metastasis: an imbalance of positive and negative regulation.

  1991cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Transforming Growth Factor- (cid:1) -activated Kinase-1 (TAK1), a MAP3K, Interacts with Smad Proteins and Interferes with Osteogenesis in Murine Mesenchymal Progenitors* □ S

  year unknowncited by this paper

• Codon-optimized human Smad7 gene therapy enhances skeletal muscle mass and function in a murine model of Duchenne muscular dystrophy

  2025cites this paper
• Smad7 is a negative regulator of immunogenic cell death in colorectal cancer

  2025cites this paper
• Novel Role of Microtubule-Associated Serine/Threonine Kinase Like as a Good Prognostic Factor in Oral Squamous Cell Carcinoma and Evidences for a Link with Smad7

  2025influential citation
• UVB‐Protective Effects and Its Mechanisms of Vitis amurensis Rupr. Methanol Extract in Human Primary Dermal Fibroblasts

  2025cites this paper
• KAT2B inhibits proliferation and invasion via inactivating TGF-β/Smad3 pathway-medicated autophagy and EMT in epithelial ovarian cancer

  2025cites this paper
• Murine toxicology assessment of avgn7.2, a novel gene therapeutic for inclusion body myositis and other muscle wasting diseases

  2025cites this paper
• Role of the TGF-β/SMAD pathway in tumor radioresistance to boron neutron capture therapy (BNCT) in a human cell line of colon adenocarcinoma.

  2025cites this paper
• Unveiling the TGF-β/Smad signaling in renal carcinoma progression: Prognostic and therapeutic insights.

  2025cites this paper
• OTUD1 inhibits endometriosis fibrosis by deubiquitinating MADH7.

  2025cites this paper
• Advancing Colorectal Cancer Diagnostics from Barium Enema to AI-Assisted Colonoscopy

  2025cites this paper
• The role of long noncoding RNA DGCR5 in cancers: Focus on molecular targets

  2024cites this paper
• Reduced S-nitrosylation of TGFβ1 elevates its binding affinity toward the receptor and promotes fibrogenic signaling in the breast

  2024cites this paper
• miRNAs in Signal Transduction of SMAD Proteins in Breast Cancer

  2024cites this paper
• Frizzled 6 endows high‐grade serous ovarian cancer with stem‐like properties and chemoresistance

  2024cites this paper
• Dynamics of transforming growth factor β signaling and therapeutic efficacy

  2023cites this paper
• Genetic analysis and allele-specific expression of SMAD7 3'UTR variants in human colorectal cancer reveal a novel somatic variant exhibiting allelic imbalance.

  2023cites this paper
• Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway

  2023cites this paper
• Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression

  2023cites this paper
• The role of KLF transcription factor in the regulation of cancer progression.

  2023cites this paper
• ALKBH1‐mediated m1A demethylation of METTL3 mRNA promotes the metastasis of colorectal cancer by downregulating SMAD7 expression

  2022cites this paper
• Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer

  2022cites this paper
• Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells

  2022cites this paper
• Expression of miR-18a-5p, miR-144-3p, and miR-663b in colorectal cancer and their association with cholesterol homeostasis.

  2021cites this paper
• Title : Regulatory start-stop elements in 5 ’ untranslated regions pervasively modulate translation

  2021cites this paper
• Identification of genes related to growth traits from transcriptome profiles of duck breast muscle tissue

  2021cites this paper
• MiR-410-3p facilitates Angiotensin II–induced cardiac hypertrophy by targeting Smad7

  2021cites this paper
• Long non-coding RNA ARHGAP5-AS1 inhibits migration of breast cancer cell via stabilizing SMAD7 protein

  2021cites this paper
• Regulatory start-stop elements in 5’ untranslated regions pervasively modulate translation

  2021cites this paper
• Expression and function of Smad7 in autoimmune and inflammatory diseases

  2021cites this paper
• Transcriptomic analysis reveals that combinations of vitamins A, D2, and D3 have synergistic effects in HCT-116 colon cancer cells by altering the expression of genes involved in multiple canonical pathways including apoptosis, regulation of the...

  2021influential citation
• Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer

  2021cites this paper
• Drosophila MOV10 regulates the termination of midgut regeneration.

  2021cites this paper
• WHSC1/NSD2 regulates immune infiltration in prostate cancer

  2021cites this paper
• MicroRNA-505, Suppressed by Oncogenic Long Non-coding RNA LINC01448, Acts as a Novel Suppressor of Glycolysis and Tumor Progression Through Inhibiting HK2 Expression in Pancreatic Cancer

  2021cites this paper
• Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes‐Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans

  2020cites this paper
• Transforming growth factor beta (TGF-β) activity in immuno-oncology studies.

  2020cites this paper
• Decreasing Microtubule Actin Cross-Linking Factor 1 Inhibits Melanoma Metastasis by Decreasing Epithelial to Mesenchymal Transition

  2020cites this paper
• Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma.

  2020cites this paper
• The association between SMAD7 polymorphisms and colorectal cancer susceptibility as well as clinicopathological features in the Iranian population

  2020cites this paper
• Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors

  2020cites this paper
• Smad7 Enhances TGF-β-Induced Transcription of c-Jun and HDAC6 Promoting Invasion of Prostate Cancer Cells

  2020cites this paper
• MiR-581/SMAD7 Axis Contributes to Colorectal Cancer Metastasis: A Bioinformatic and Experimental Validation-Based Study

  2020cites this paper
• Current perspectives on inhibitory SMAD7 in health and disease

  2020cites this paper
• LncRNA DGCR5 plays a tumor-suppressive role in glioma via the miR-21/Smad7 and miR-23a/PTEN axes

  2020cites this paper
• Potentials of miR-15/16 targeting cancer stem cell pathways: Novel implication in cancer chemotherapy

  2020cites this paper
• Integrated TCGA and GEO analysis showed that SMAD7 is an independent prognostic factor for lung adenocarcinoma

  2020cites this paper
• Lactobacillus Attenuate the Progression of Pancreatic Cancer Promoted by Porphyromonas Gingivalis in K-rasG12D Transgenic Mice

  2020cites this paper
• The dichotomous role of TGF-β in controlling liver cancer cell survival and proliferation.

  2020cites this paper
• Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer

  2020cites this paper
• Long Noncoding RNA ARHGAP5-AS1 Inhibits Migration of Breast Cancer Cell via Stabilizes SMAD7 Protein

  2020influential citation
• TGFβ Family Signaling Pathways in Pluripotent and Teratocarcinoma Stem Cells’ Fate Decisions: Balancing Between Self-Renewal, Differentiation, and Cancer

  2019cites this paper
• Bone morphogenetic protein signaling in breast cancer progression

  2019influential citation
• Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma

  2019cites this paper
• Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer

  2019cites this paper
• GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients

  2019cites this paper
• Epigenetic‐based therapy for colorectal cancer: Prospect and involved mechanisms

  2019cites this paper
• Hepatic Smad7 overexpression causes severe iron overload in mice.

  2018cites this paper
• Role of SMAD proteins in colitis-associated cancer: from known to the unknown

  2018cites this paper
• Paeoniflorin exerts protective effect on radiation-induced hepatic fibrosis in rats via TGF-β1/Smads signaling pathway.

  2018cites this paper
• SMAD7 methylation as a novel marker in atherosclerosis.

  2018cites this paper
• Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies

  2018cites this paper
• Impact of cancer mutational signatures on transcription factor motifs in the human genome

  2018cites this paper
• Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer

  2018cites this paper
• Impact of Mesenchymal Stem Cells and Vitamin D on Transforming Growth Factor Beta Signaling Pathway in Hepatocellular Carcinoma in Rats

  2018cites this paper
• Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer

  2018cites this paper
• Deficiency of tumor suppressor Merlin facilitates metabolic adaptation by co-operative engagement of SMAD-Hippo signaling in breast cancer

  2018cites this paper
• Deregulation of Negative Controls on TGF-β1 Signaling in Tumor Progression

  2018cites this paper
• Rosuvastatin improves myocardial hypertrophy after hemodynamic pressure overload via regulating the crosstalk of Nrf2/ARE and TGF‐&bgr;/ smads pathways in rat heart

  2018cites this paper
• The Role of TGF-andbeta; in Gastrointestinal Cancers

  2018cites this paper
• Model based on GA and DNN for prediction of mRNA-Smad7 expression regulated by miRNAs in breast cancer

  2018cites this paper
• Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk

  2018cites this paper
• SMAD7 in keratinocytes promotes skin carcinogenesis by activating ATM-dependent DNA repair and an EGFR-mediated cell proliferation pathway

  2018cites this paper
• TGF-β Signaling and miRNAs Targeting for BMP7 in the Spleen of Two Necrotic Enteritis-Afflicted Chicken Lines

  2017cites this paper
• miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition

  2017cites this paper
• Elucidating the role of SMAD7 in pancreatic cancer through in vivo studies

  2017cites this paper
• Hepatocyte-specific Smad7 deletion accelerates DEN-induced HCC via activation of STAT3 signaling in mice

  2017cites this paper
• Bayesian and frequentist analysis of an Austrian genome-wide association study of colorectal cancer and advanced adenomas

  2017cites this paper
• NR2F2 inhibits Smad7 expression and promotes TGF-β-dependent epithelial-mesenchymal transition of CRC via transactivation of miR-21.

  2017cites this paper
• Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers

  2016cites this paper
• Correction: Elevating CLIC4 in Multiple Cell Types Reveals a TGF-β Dependent Induction of a Dominant Negative Smad7 Splice Variant

  2016cites this paper
• SMAD7, an antagonist of TGF-beta signaling, is a candidate of prenatal skeletal muscle development and weaning weight in pigs

  2016cites this paper
• microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7

  2016cites this paper
• Artificial Neural Networks to Predict Regulation between Smad7 and miRNA on Breast Cancer

  2016cites this paper
• Elevating CLIC4 in Multiple Cell Types Reveals a TGF-β Dependent Induction of a Dominant Negative Smad7 Splice Variant

  2016cites this paper
• Integrated genomic and transcriptomic analyses of radiation-induced malignancies

  2016influential citation
• P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.

  2016cites this paper
• Loss of KLF4 and Consequential Downregulation of Smad7 Exacerbate Oncogenic TGF-β Signaling in and Promote Progression of Hepatocellular Carcinoma

  2016cites this paper
• Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?

  2016cites this paper
• Role of tumor-associated macrophages in the Hexim1 and TGFβ/SMAD pathway, and their influence on progression of prostatic adenocarcinoma.

  2016cites this paper
• Requirement and Function of Hippo Pathway Signaling in the Mammalian Gastrointestinal Tract: A Dissertation

  2016cites this paper
• Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5

  2016cites this paper
• Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling*

  2015cites this paper
• Characterization of cellular and molecular responses of human gliobastoma to transforming growth factor-b signalling pathway inhibition

  2015cites this paper
• miR-21 и miR-155 в регуляции TGF-β1/SMAD-сигнального пути в линии клеток рака молочной железы с различным метастатическим потенциалом

  2015cites this paper
• Polymorphism of SMAD7 gene (rs2337104) and risk of colorectal cancer in an Iranian population: a case-control study

  2014cites this paper
• Transforming Growth Factor (TGF)-β-Induced MicroRNA-216a Promotes Acute Pancreatitis Via Akt and TGF-β Pathway in Mice

  2014cites this paper
• SMAD7: a timer of tumor progression targeting TGF-β signaling

  2014cites this paper
• Lack of influence of the SMAD7 gene rs2337107 polymorphism on risk of colorectal cancer in an Iranian population.

  2014cites this paper
• World Journal of Hepatology

  year unknowncites this paper